Asset Dedication LLC’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $21.9K | Buy |
417
+213
| +104% | +$11.3K | ﹤0.01% | 643 |
|
|
2026
Q1 | $11.3K | Hold |
204
| – | – | ﹤0.01% | 746 |
|
|
2025
Q4 | $10K | Sell |
204
-702
| -77% | -$32.7K | ﹤0.01% | 780 |
|
|
2025
Q3 | $39.1K | Sell |
906
-6,464
| -88% | -$252K | ﹤0.01% | 551 |
|
|
2025
Q2 | $283K | Buy |
7,370
+7,166
| +3,513% | +$274K | 0.02% | 273 |
|
|
2025
Q1 | $7.9K | Hold |
204
| – | – | ﹤0.01% | 796 |
|
|
2024
Q4 | $6.9K | Hold |
204
| – | – | ﹤0.01% | 815 |
|
|
2024
Q3 | $8.34K | Sell |
204
-221
| -52% | -$9.04K | ﹤0.01% | 828 |
|
|
2024
Q2 | $16.4K | Buy |
425
+141
| +50% | +$5.93K | ﹤0.01% | 724 |
|
|
2024
Q1 | $12K | Hold |
284
| – | – | ﹤0.01% | 660 |
|
|
2023
Q4 | $10K | Hold |
284
| – | – | ﹤0.01% | 674 |
|
|
2023
Q3 | $10K | Hold |
284
| – | – | ﹤0.01% | 680 |
|
|
2023
Q2 | $10K | Hold |
284
| – | – | ﹤0.01% | 673 |
|
|
2023
Q1 | $10K | Hold |
284
| – | – | ﹤0.01% | 662 |
|
|
2022
Q4 | $10K | Hold |
284
| – | – | ﹤0.01% | 660 |
|
|
2022
Q3 | $8K | Sell |
284
-1
| -0.4% | -$38 | ﹤0.01% | 660 |
|
|
2022
Q2 | $15K | Sell |
285
-8
| -3% | -$442 | ﹤0.01% | 314 |
|
|
2022
Q1 | $15K | Sell |
293
-280
| -49% | -$15.2K | ﹤0.01% | 603 |
|
|
2021
Q4 | $30K | Sell |
573
-280
| -33% | -$14.6K | ﹤0.01% | 480 |
|
|
2021
Q3 | $40K | Buy |
853
+8
| +0.9% | +$402 | 0.01% | 451 |
|
|
2021
Q2 | $42K | Hold |
845
| – | – | 0.01% | 429 |
|
|
2021
Q1 | $38K | Buy |
845
+560
| +196% | +$25.4K | 0.01% | 365 |
|
|
2020
Q4 | $14K | Buy |
285
+80
| +39% | +$3.67K | ﹤0.01% | 507 |
|
|
2020
Q3 | $10K | Hold |
205
| – | – | ﹤0.01% | 526 |
|
|
2020
Q2 | $10K | Buy |
+205
| New | +$10.5K | ﹤0.01% | 454 |
|
|
2020
Q1 | – | Sell |
-125
| Closed | -$7K | – | 702 |
|
|
2019
Q4 | $7K | Sell |
125
-275
| -69% | -$15.3K | ﹤0.01% | 501 |
|
|
2019
Q3 | $21K | Buy |
+400
| New | +$20.6K | 0.01% | 382 |
|
|
2019
Q1 | – | Sell |
-160
| Closed | -$8K | – | 627 |
|
|
2018
Q4 | $8K | Buy |
+160
| New | +$7.88K | ﹤0.01% | 447 |
|
|
2016
Q4 | – | Sell |
-560
| Closed | -$30K | – | 394 |
|
|
2016
Q3 | $30K | Buy |
+560
| New | +$30.7K | 0.02% | 226 |
|
|
2016
Q2 | – | Sell |
-45
| Closed | -$2K | – | 388 |
|
|
2016
Q1 | $2K | Hold |
45
| – | – | ﹤0.01% | 371 |
|
|
2015
Q4 | $2K | Buy |
+45
| New | +$2.29K | ﹤0.01% | 559 |
|
Other funds holding GSK
JEST
Asset Dedication LLC's GSK Position: Q2 2026 in Review
Asset Dedication LLC increased its GSK (GSK) stake by 104% in Q2 2026, buying an estimated $11.3K and bringing the position to 417 shares worth $21.9K. The position accounts for ﹤0.01% of the portfolio, ranked #643.
Asset Dedication LLC first reported a position in GSK in Q4 2015 and has held it in 31 quarters since. The position peaked at $283K in Q2 2025. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.
- Asset Dedication LLC held 417 shares of GSK worth $21.9K as of Q2 2026.
- Asset Dedication LLC bought 213 GSK shares in Q2 2026, an estimated $11.3K.
- GSK made up ﹤0.01% of Asset Dedication LLC's portfolio in Q2 2026, its #643 holding.
- Asset Dedication LLC first reported a position in GSK in Q4 2015 and has held it in 31 quarters since.
- Asset Dedication LLC's GSK position peaked at $283K in Q2 2025.
- 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.
Based on Asset Dedication LLC's 13F filing for Q2 2026, filed 30 Jul 2026.